Skip to content

Controlling Hyperglycemia Among Minority Population

Controlling Hyperglycemia Among Minority Population (CHAMP): A Randomized Controlled Trial of Two Diabetes Interventions for Underserved Communities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02681718
Acronym
CHAMP
Enrollment
272
Registered
2016-02-12
Start date
2016-01-31
Completion date
2017-09-30
Last updated
2018-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

A1C≥9%, minorities, economically disadvantaged

Brief summary

The purpose of this study is to compare the efficacy of three approaches in diabetes management: (1) community health worker (CHW) education; (2) text messaging; and (3) usual hospital-based care. The goal is to determine the most cost-effective method of diabetes management among an economically-disadvantaged, minority population.

Detailed description

The CHAMP study will test the efficacy of two interventions designed to decrease uncontrolled hyperglycemia (defined as Hemoglobin-A1C (A1C) at or above 9%) among adults with diabetes. Patients from a safety-net hospital will be randomized into three groups: 1) a control group, 2) an intervention providing diabetes self-care text messages, or 3) an intervention using community health workers to provide diabetes education and linkage to care. Secondary objectives include increasing diabetes knowledge, improving diabetes self-management, and increasing use of primary care (i.e., make one visit to the physician in 6 months) among the intervention participants. A cost-effectiveness analysis will determine the most appropriate way to reduce the burden of uncontrolled diabetes.

Interventions

BEHAVIORALCommunity health worker education

Diabetes self-management education by community health workers

BEHAVIORALCell phone text messaging

Diabetes self-management education through cell phone text messaging

Sponsors

Blue Cross Blue Shield
CollaboratorOTHER
Sinai Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

\*Hyperglycemia with A1C ≥9%

Exclusion criteria

* Lives greater than 20 miles driving distance from Mount Sinai Hospital * Pregnant women with gestational diabetes * Advanced end-organ complications due to diabetes that include: end-stage renal disease, stroke with paresis, Congestive Heart Failure (NYHA class III or IV), or other major end-organ complication of diabetes * Receiving treatment for a major psychiatric disorder (i.e. schizophrenia) * Unable to understand and give informed consent in either English or Spanish * Currently or previously participated in a diabetes research study * Family member currently enrolled in a diabetes research study * Previously received diabetes care related cell phone text messages * Unable to receive text messages 3-4 times per week * Living in a homeless shelter or temporary housing * Plans to travel outside of the United States for more than 3 months in next year

Design outcomes

Primary

MeasureTime frameDescription
Difference in Hemoglobin A1C (CHW vs. Control)6 monthsTo assess whether there is a statistically significant difference in HbA1C level between CHW and control groups at 6 months follow-up.
Difference in Hemoglobin A1C (Text Message vs. Control)6 monthsTo assess whether there is a statistically significant difference in HbA1C level between text message and control groups at 6 months follow-up.

Secondary

MeasureTime frameDescription
Mean change in diabetes distress scores6 monthsProblem areas in diabetes (PAID-5) scale
Mean change in participants' beliefs about using insulin scores6 monthsInsulin treatment appraisal (ITAS) scale
Percentage change in diabetes knowledge test scores6 monthsMichigan Diabetes and Research Center Knowledge test
Percentage of participants who visited a physician due to a diabetes related follow-up6 monthsSelf- reported
Mean changes in diabetes self-care activities6 monthsDiabetes self-care activities include: diet, physical activity, self-monitoring of blood glucose, foot-care, and smoking
Mean change in diabetes self-efficacy scores6 monthsPerceived competence in diabetes scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026